In our previous study, a rat homolog of human nonmuscle myosin heavy chain-B (nmMHC-B) was identi®ed by mRNA dierential display comparing of transformed against nontransformed Rat 6 cells overexpressing mutant p53 val135 gene. The nmMHC-B was found to be expressed in normal Rat 6 embryo ®broblast cell line, but markedly suppressed in the mutant p53 val135 -transformed Rat 6 cells. To examine the possible involvement of nmMHC-B in cell transformation, we ®rst cloned and sequenced the full length cDNA of rat nmMHC-B, which was then cloned into an ecdysoneexpression vector. The resulting construct was introduced into the T2 cell line, a mutant p53 val135 -transformed Rat 6 cells lacking the expression of the endogenous nmMHC-B. The clonal transfectants, expressing muristerone Ainduced nmMHC-B, displayed a slightly¯atter morphology and reached to a lower saturation density compared to the parental transformed cells. Reconstitution of actin ®lamental bundles was also clearly seen in cells overexpressing the nmMHC-B. In soft agar assays, nmMHC-B transfectants formed fewer and substantially smaller colonies than the parental cells in response to muristerone A induction. Moreover, it was strikingly eective in suppressing the tumorigenicity of the T2 cells when tested in nude mice. Thus, the nmMHC-B, known as a component of the cytoskeletal network, may act as a tumor suppressor gene. Our current ®nding may revealIntroduction Myosin, a cytoskeletal protein conserved among all eukaryotic cells, plays a major role in muscle contraction. The conventional myosin (class II myosin) molecule possesses a hexameric structure composed of one pair of heavy chains of approximately 200 kD and two pairs of light chains of about 15 ± 28 kD. Myosin is expressed in both muscle and non-muscle cells. The role of myosin in muscle contraction is well known, whereas the function of myosin in nonmuscle cells is less clear. Evidence suggests that myosin plays a role in cytokinesis (De Lozanne and Spudich, 1987) , cell proliferation (Rovner et al., 1986; Simons et al., 1992) , secretion (Ludowyke et al., 1989) and migration (Warrick and Spudich, 1987) . Defects in myosins are thought to be associated with several genetic lesions (for review see Gulick and Rayment, 1997) . Two major isoforms of nonmuscle myosin heavy chain A and B (nmMHC-A and -B) have been identi®ed in vertebrate cells. The cDNAs of nmMHC have been cloned from human, mouse, chicken and xenopus (Choi et al., 1996; Phillips et al., 1995; Saez et al., 1990; Katsuragawa et al., 1989; Bhatia-Dey et al., 1993) . A recent study indicates that nmMHC-B is required for normal development of mouse heart and that its absence results in abnormal development of cardiac myocyte (Tullio et al., 1997) . Unique forms of isoform B have also been identi®ed in chicken and human neuronal cells (Takahashi et al., 1992; Itoh and Adelstein, 1995) and was reportedly involved in neuronal dierentiation. A study by Mummert and Schenground (1997) indicated that nmMHC-B has a function in neurite formation.
In our recent eort to elucidate the role of the mutant p53 gene in neoplastic transformation, a temperature sensitive mutant p53 val135 (valine at position 135) was introduced into normal Rat 6 embryo ®broblasts that retained the endogenous wild type p53. One of the resulting p53 val135 -overexpressors, R6#13-8, showed no obvious alteration in growth properties; however, they did exhibit frequent spontaneous transformation in prolonged cultures. The T2 clonal cell line, derived from one of the spontaneous transformed foci of R6#13-8 cultures, showed typical transforming morphology and formed tumors in nude mice. In addition, the cells no longer expressed the vectored p53, suggesting secondary changes occurred in these cells leading to cell transformation (Yam et al., 1999) . In an eort to identify events related to mutant p53 val135 -induced malignant phenotypes, R6#13-8, and its derived spontaneous transformant T2 cell line were employed for mRNA dierential display. After a systematic screening with 80 sets of primers, three signi®cant cDNA fragments (Yam et al., 1999) were identi®ed. One of these was a 351 bp fragment found down-regulated in T2 and it shared 93% homology with the 3' terminus of the human nmMHC-B gene. Using the 351 bp fragment as a probe in a Northern blot analysis, a 7.6 kb transcript corresponding to the reported human nmMHC-B was detected among the normal Rat 6, untransformed Rat 6 derivatives overexpressing p53 val135 , but not in the spontaneous transformants derived from R6#13-8 cultures. The levels of transcript seem to be inversely correlated with the degree of transformation of the tested cell lines.
Although nmMHC-B is involved in diverse cellular functions, there is no indication that it participates in cell transformation. Early studies on cytoskeletal proteins such as actin, tropomyosin and vinculin have provided evidence that reduction of cytoskeletal proteins are often a key feature of cell transformation (for a review, see Ben-Ze'ev, 1997) . Later studies also showed that overexpression of a-actinin, vinculin or tropomyosin could reverse transforming phenotypes of certain transformed cells (GluÈ ck et al., 1993; FernaÂ ndez et al. 1992 , Boyd et al., 1995 . Moreover, an interesting notion has emerged that some cell adhesion molecules, known to be intimately associated with the cytoskeletal network, may work as tumor suppressors (Tsukita et al., 1993) . All these observations prompt us to hypothesize that suppression of nmMHC-B in T2 cells might contribute in part to the malignant phenotypes of T2 cells, which may be reversed by re-introducing the gene back to the cells.
To investigate the role of nmMHC-B in cell transformation, T2 transformed cells that expressed negligent levels of nmMHC-B were transfected with the rat nmMHC-B (designated as r-nmMHC-B) gene under an ecdysone expression system. Results showed that overexpression of r-nmMHC-B slightly¯attened cell morphology, lowered saturation densities and partially reversed the anchorage-independent growth of T2 cells. Intriguingly, r-nmMHC-B transfected T2 cells were non-tumorigenic when inoculated into nude mice. Based on this observation, r-nmMHC-B may act as a tumor suppressor gene at least in cells transformed by the mutated p53 tumor suppressor gene.
Results

Suppression of nmMHC-B, but not -A isoform was observed in spontaneous transformant T2 cell line
In organisms and cell types studied so far, the conventional myosin II consists of two major isoforms, MHC-A and -B, encoded by dierent genes (Simons et al., 1991) . Using A-and B-speci®c polyclonal antibodies as probes, the extracts of Rat 6, R6#13-8, and T2 cells were analysed by immunoblotting ( Figure 1A) . The nmMHC-A and -B both yield proteins with 220 kD in size. In order to verify the speci®city of each antibody, Cos7 cells (known to express only B isoform), and human serum platelets (known to express only A isoform) were included in the study as positive controls. Interestingly, the expression of A-isoform is unaected in the T2 cell line. Similar results were obtained by immuno¯uor-escent staining ( Figure 1B ). Although both isoforms are coexpressed in most cell types, lacking expression of one or the other isoform has no apparent eect on cell viability as evidenced by the growth of T2, Cos7 cells and others, such as the rat mast cell line RBL-2H3 described by Choi et al. (1996) .
Cloning of the full-length rat nmMHC-B cDNA
To con®rm and further characterize the putative gene homologous to nmMHC-B, the 351 bp rat cDNA fragment previously identi®ed was used as a probe to screen a rat brain cDNA library (Stratagene #936501). Two isolated overlapping positive clones provide sequence information for a 7648 bp full length cDNA of r-nmMHC-B (GenBank AF139055), which consists of an open reading frame of 5928 bp coding region, preceded by 188 nucleotides and tailed with 1532 bp of untranslated region. Compared to homologs of human and chicken (GenBank M69181) (Phillips et al., 1995) and (GenBank M93676) (Katsuragawa et al., 1989) , the rat homolog has a longer 5' untranslated region (UTR), which might be derived from a minor upstream transcription initiation site, as suggested by Weir and Chen (1996) . The 3' UTR is 69% homology to the human sequences (Phillips et al., 1995) , however, there are two stretches of sequences (6226 ± 6707 and 6941 ± 7620) which share 86 and 78% to those of human, suggesting that the well conserved 3' UTR may play an important role in regulating nmMHC-B function. The r-nmMHC-B exhibit 99 and 96% homology in amino acid sequences, and 89 and 83% homology in nucleotide sequences, to human and chicken respectively (Phillips et al., 1995; Katsuragawa et al., 1989) . The deduced amino acid sequences of r-nmMHC-B were compared to those from human and chicken shown in Figure 2 . The reported unique sequence insertions (Takahashi et al., 1992; Itoh et al., 1995) are not found in rnmMHC-B.
Construction and expression of r-nmMHC-B vector in T2 cells
To address whether the suppression of nmMHC-B in T2 cells might have contributed to its acquired transforming phenotypes, the full length r-nmMHC-B cDNA was cloned into pIND/Hygro vector, which contains the ecdysone response element sequences and the hygromycin gene. The resulting vector pIND/ nmMHC-B together with the vector pVgRXR carrying both the retinoid X receptor and an ecdysone receptor and a zeocin gene were cotransfected into T2 cells, followed by zeocin and hygromycin selections. Two stable transfectants, T2/MHC-B#33 (MHC#33) and T2/MHC-B#44 (MHC#44), which showed inducible nmMHC-B expression upon induction in a dosage dependent manner ( Figure 3A) , were selected for later study. A T2 derivative-T2C expressing only the pIND and pVgRXR backbone vectors was also established as a control cell line. Based on the screenings on nmMHC-B expression, all the tested transfectants showed basal levels of nmMHC-B in the absence of the inducer, indicating that there is a leakage in the system. In general, MHC#44 displays lower background level of nmMHC-B under uninduced condition and is more responsive upon muristerone A induction compared to the MHC#33 clone ( Figure 3A ). Neither the parental T2 nor T2C expresses any detectable nmMHC-B protein.
With regard to morphology, the parental T2 and vectors-expressing T2C cells showed a typical transforming morphology with short, refractile cell bodies that were densely packed, while the stable MHC-B transfectants displayed a slightly¯attened morphology in the absence of inducer ( Figure 3B ). MHC#44 was atter than MHC#33. Addition of muristerone A seemed to further¯atten the morphology of both clones slightly, while imposed no eect on T2 or T2C cells ( Figure 3B ).
Immunofluorescent localization of nmMHC-B in the transfectants
We then further characterized MHC#44 by immunouorescent staining and observed that the subcellular distribution of the exogenous r-nmMHC-B was quite dierent from that observed in Rat 6 or R6#13-8 cells ( Figure 3C ). In Rat 6 cells, the endogenous nmMHC-B was diusely throughout the cytoplasm, whereas the exogenous r-nmMHC-B was densely accumulated around the nuclear envelope of MHC#44, irrespective of stages of cell growth or division, which became more prominent upon addition of the inducer. As expected, nmMHC-B is not detectable in T2 cells, induced or uninduced ( Figure 3C ). The nmMHC-B-expressing cells showed reduction in saturation density and anchorage-independent growth
The eect of nmMHC-B on growth rate and saturation density was examined in MHC#44 clone. Figure 4A shows growth curves of MHC#44 cells in the absence or presence of 2, 5, and 10 mM of muristerone A. There are no apparent dierences in growth rate among the experimental groups; however, the saturation density was steadily decreased as the concentrations of inducer steadily increased. Early western blotting showed that the induced level of r-nmMHC-B was proportionally correlated with the dosage of the applied inducer. In the same experiment, a single`day 8' time point of T2 cells in the absence or presence of 10 mM inducer was included. The saturation density of MHC#44 reached only 46 and 32 % of the control T2 cells in both uninduced and induced conditions. To ensure that the growth retardation observed in MHC#44 cells was not simply due to the nonspeci®c toxic eect of muristerone A, T2 and MHC#44 were treated with various dosages of muristerone A for 8 days, and then were Figure 2 Alignment of amino acid sequences of r-nmMHC-B (Rat) (GenBank AF139055) with those of human (Hum) (GenBank M69181) and chicken (Chk) (GenBank M93676) nmMHC-B. Identical amino acid residues are indicated by dashes and amino acid residues dierent from that of r-nmMHC-B are shown. Locations of the two insertions in chicken nmMHC-B are indicated by the arrowheads (~). The amino acid sequences of the two insertions are PESPKPVKHQ (insert after residue 211) and EIQNIQRACFYDNITGLHDPP (insert after residue 621). The ATP binding site (a.a. 159 ± 194), actin binding site, 28-residue repeat (a.a.857 ± 884) of the a-helical coiled core are underlined. The a-helical core domain (a.a. 843 ± 933) is marked by the arrowbars counted for cell number. Compared to the untreated T2 cells, the treated T2 show 15 and 17% growth reduction, whereas MHC#44 cells show 50 and 58% reduction under the treatment of 5 and 10 mM muristerone A, respectively ( Figure 4A ). Despite the fact that muristerone A was slightly toxic at high concentration, the growth inhibition seen in MHC#44 cells was much more striking than in the T2 cells. We therefore conclude that reduced saturation density was mainly due to the eect of r-nmMHC-B expressed in MHC#44 cells. It is worth mentioning that there was no obvious cell death in the induced cultures, suggesting that overexpression of r-nmMHC-B might have restored the contact inhibition property of the T2 cells, but did not exert a direct killing eect on cells. In fact, the r-nmMHC-B expressing cells appeared healthy, although somewhat slow growing, under high dosages of muristerone A.
To investigate the eect of nmMHC-B on the malignant phenotypes of the T2 cells in vitro, the uninduced and induced MHC#44 cells were examined for anchorage-independent growth in semi-soft agar as described (Housey et al., 1988) . Rat 6 and R6#13-8 were also included for comparison. As shown in Figure  4B and Table 1 , normal Rat 6 cells remained as single cells; R6#13-8 cells formed few small colonies; while T2 transformants formed numerous large colonies. The uninduced MHC#44 cells, which constitutively expressed low levels of nmMHC-B, formed similar numbers, but much smaller colonies than the parental T2 cells ( Figure 4C and Table 1 ). MHC#44 cultures induced with 1 and 5 mM of muristerone A, respectively, showed signi®cant reductions both in numbers and sizes of agar colonies. These results indicate that the induced expression of r-nmMHC-B is responsible for the partial reversion of the anchorage independent growth of the T2 cells.
Reconstitution of actin filaments in T2 cells overexpressing r-nmMHC-B
Disruption of cytoskeletal network is one of the characteristic features of cell transformation, irrespective of the course of transformation. To examine the status of the cytoskeletal structure, we stained the actin ®laments of R6, R6#13-8, T2C, and MHC#44 with FITC-phalloidin, a phallotoxin that binds to ®lamen-tous actin. Like other non-transformed cells, the actin cable network was preserved in normal R6 and nontransformed R6#13-8 cells, but not in the fully transformed T2C (Figure 5a ± c) . On the other hand, the MHC#44 cells, which displayed reversed transforming phenotypes, have nicely restored the actin ®lamentous system that was lost in the T2C cells lacking the expression of nmMHC-B (Figure 5d ). Treatment with muristerone A did not signi®cantly enhance the actin ®lament bundles further in any of the test cell lines. In fact, under uninduced condition, the intensity of the actin bundles in MHC#44 seemed to be the same, except, they were less orderly compared to the actin ®laments in R6 and R6#13-8 cells. This partial restoration of actin organization of MHC#44 is in line with the partial reversed transforming phenotypes described above in this report.
r-nmMHC-B suppresses tumorigenicity of T2 cells
Data above suggested that expression of r-nmMHC-B in T2 partially reversed its transforming phenotypes, namely the cell morphology, saturation density and anchorage independent growth, and actin ®laments. We therefore performed in vivo tumorigenicity tests in nude mice to assess the transforming status of MHC#44. Prior to the injection, MHC#44 cells were induced with or without 10 mM muristerone A for 48 h. To preclude any adverse eect of muristerone A on animals, T2 cells induced by same dosage of muristerone A were included in the experiment, in addition to the uninduced. At the end of treatment, cells were harvested and washed once with cold PBS, then resuspended in PBS and counted. For each group, three injection sites, each with 3610 6 cells, were performed. Results of such experiment are shown in Table 2 (Expt. I). T2 cells, treated or untreated with muristerone A, induced palpable tumors in all sites one week after the injections, and the tumors rapidly grew to sizes ranging from 2 ± 7.5 cm 3 by the end of the second week, when mortality began to be seen among the tumor bearing animals. In contrast, no tumor was detected at the sites injected with r-nmMHC-B expressors, either induced or uninduced. At the end of 2 weeks, a small palpable lump was observed at one of the injection sites with uninduced r-nmMHC-B expressors, and this was later veri®ed by surgical examination. Suppression of malignant transformation by nmMHC-B was very striking, especially in view of the low level of nmMHC-B in the uninduced cells. To verify the anti-tumorigenic activity of r-nmMHC-B, we carried out another nude mice assay on two transfectants: MHC#44 and #33 under induced and uninduced conditions. Once again, MHC#44 produced no tumor (Table 2, Expt.II), while T2 gave rise to large tumors within two weeks. MHC#33 induced tumors at all injection sites; however, tumor size was signi®cantly smaller than in the control group. T2C, the backbone vectors clone, when injected into nude mice, produced large tumors ranging from 4.8 ± 6.7 cm 3 under both induced and uninduced situations within the same latency period as the parental T2 cells.
Discussion
In this report, we described the cloning and characterization of a rat homolog to the known nmMHC-B gene. This homolog was previously found downregulated in transformed cells which had arisen spontaneously in the mutant p53 val135 -overexpressing Rat 6 ®broblasts (Yam et al., 1999) . Upon acquiring the full length cDNA sequences, we subsequently constructed a r-nmMHC-B expression vector driven by an ecdysone-inducible promoter; the r-nmMHC-B vector was then introduced back to one of the spontaneous transformant T2 cells lacking the expression of nmMHC-B, but not of -A. The restoration of the r-nmMHC-B expression in T2 partially reversed the transforming phenotypes of T2 cells in terms of cell morphology, saturation density, and anchorage-independent growth in an ecdysone-dependent fashion. The actin network, a key feature in cell transformation, clearly reappeared, which provides a strong indication of the reversion of transforming phenotypes. Furthermore, expression of r-nmMHC-B in T2 drastically suppressed the tumorigenic activity of T2 tested in nude mice. It might seem surprising to observe such strong anti-tumor eects with both r-nmMHC-B transfectants in the uninduced condition where little leakage of r-nmMHC-B was detected, and when the dierence between the T2 and uninduced MHC#44 in soft agar growth was rather mild (dierence in size, but not in terms of number of colonies); however, such discrepancy between anchorage independence growth and tumorigenicity has been documented elsewhere (for review, see Stanbridge and Wilkinson, 1980) . This may well be a phenotypic trait unique to nmMHC-Bexpressing cells.
In addition to the novel tumor suppression eect of r-nmMHC-B, the other intriguing ®nding in the current study is the unusual subcellular distribution of the ecdysone-inducible r-nmMHC-B. Endogenous nmMHC-B is evenly distributed in the cytoplasm of normal Rat 6 or untransformed R6#13-8 cells, while vectored nmMHC-B is distinctly localized in the nuclear membrane of MHC#44, becoming even more prominent in the presence of inducer ( Figure 3C ). According to the study in xenopus (Kelley et al., 1996) , nmMHC-B is present in the cell cortex and diusely distributed in the cytoplasm; this concurs with our observation in Rat 6 and R6#13-8 cells. During prophase, the nmMHC-B distributes to the nuclear membrane. However, unlike the ®nding in our study, they reported that xenopus nmMHC-B resumed its interphase localization by metaphase, while our vectored r-nmMHC-B distributed to the nuclear membrane at all stages of cell cycle. It was suggested by the authors that nmMHC-B may be involved in nuclear envelope breakdown in prophase. Along this line, it is generally believed that both nmMHC-A and -B, together with actin ®laments, are likely the crucial components of the contractile ring during cytokinesis. Nevertheless, the growth rates of both nmMHC-Bexpressing cells and depleted cells are the same ( Figure  4A ). Later, we performed¯ow cytometer analysis of cell cycle on both cell lines and found no signi®cant dierence, indicating that the overexpression of nmMHC-B had no adverse eect on cell cycle progression (data not shown).
Although, prior to our current study, there has been no report of tumor suppression activity of nmMHC (or by any member of the myosin family) (Hall, 1998) , numerous studies have revealed that malignant transformations are often accompanied by disruption in cytoskeletal and adhesion proteins including actin, tropomyosin, vinculin, a-actinin. Restoration of the cytoskeletal network through gene transfer could reverse the transforming phenotypes, i.e. cell shape, cell adhesion, saturation density, anchorage-independent growth and tumorigenicity (GluÈ ck et al., 1993; FernaÂ ndez et al. 1992 , Boyd et al., 1995 Gimona et al., 1996) . Because myosin is a key member in the actin micro®lament network, it is conceivable, and was also shown in our study, that ectopic expression of myosin could alter the growth properties and tumorigenicity in a way similar to those observed with other actindependent proteins. At this point, whether reappearance of actin bundles is simply a marker for a reversed transforming phenotype, or whether it is a direct result of r-nmMHC expression is not known; however, few reports have pointed out that myosin plays a primary role in the alignment of actin ®laments, and, conversely, that inactivation of the protein results in disassembly of actin organization (Lamb et al., 1988; Honer, 1988; Fukui et al., 1990) . Along this line, recent study again showed that microinjection of myosin into REF 52 rat ®broblasts initiated the formation of actin ®lament bundles in the lamellae (Verhovsky et al., 1995) . Thus, reexpression of myosins in T2 cells might indeed trigger assembly of actin ®laments, which in turn would alter the transforming phenotypes of the cells.
Despite the clear association between tumor suppression and the assembly of cytoskeletal proteins and of related adhesion proteins in general, the underlying mechanism of the suppression remains obscure. Recent studies on oncogenes and tumor suppressor genes and their roles in signal transduction have revealed the link between adhesion plaques and key signaling pathways where various tumor suppressor genes and oncogenes are strategically located and where they coordinate rigorous checks and balances on cell signaling for a.
b.
c. d. growth and dierentiation (for review see Hunter, 1997) . Most recently, an emerging theme in the ®eld of cytoskeletal research is that the ability of Rho/Rac family proteins in regulating the actin cytoskeleton through direct targeting of the myosin light chains, which regulate the myosin heavy chains which in turn regulate the assembly of the actin-myosin stress ®ber and focal adhesion (Gimona et al., 1996; Sanders et al., 1999) . These studies provide us a clue as to the molecular basis of the role of myosin in the actin assembly in T2 overexpressing r-nmMHC-B.
As mentioned earlier, overexpression of p53 val135 did not readily induce transformation; rather, it induced instability of the host cells (re¯ected by their high spontaneous transformation rate). T2 cell line was one of the spontaneously derived transformants that exhibited altered gene expression identi®ed by the use of mRNA dierential display technique (Yam et al., 1999) . Being one of the two genes found suppressed in T2 cells, the r-nmMHC-B is now also found to possess tumor suppression activity. While the main focus of the current was on the eect and the possible mechanism of reexpression of the myosin gene, at the same time, it is equally important to the understanding of the initial cause of the suppression of r-nmMHC-B as well as the contribution of the p53 val135 in the transition from nontransformed to transformed cells. At present, the promoter activity of r-nmMHC is being investigated in both R6#13-8 and T2 cells in our laboratory. Based on what is known in the ®eld, p53 is neither a key component of spindle assembly, nor does it play a direct role in the Rho/Rac signaling pathway through which the actin stress ®bers form (Sablina et al., 1999; Esteve et al., 1998) .
Lastly, it is worthwhile to mention that downregulation of nmMHC-B was initially observed in, but not necessary restricted to, p53 val135 -transformed Rat 6 cells. As reported recently (Yam et al., 1999) , suppression of the nmMHC-B was also observed in Rat 6 cells transformed by c-H-ras, and partial suppression was also observed in v-myc, but not in those transformed by v-src, nor in mouse SVT2 cells expressing high levels of normal p53 gene. It would be interesting to explore whether the tumor suppression eects of nmMHC-B can be applied to malignant transformations induced by oncogenes other than mutant p53. Such study should help to advance our understanding of the cellular function of nmMHC.
Materials and methods
Cells and cell culture conditions
The Rat 6 embryo ®broblast cell line is a subclone of an immortalized F2408 rat embryo cell line (Freeman et al., 1967; Hsiao et al., 1986) . The R6#13-8 cell line is a derivative of the Rat 6 line infected with the retroviral vector pCH#13 carrying a temperature-sensitive mutant p53 val135 and the bacterial neomycin gene. R6#13-8 cells yield high levels of spontaneous transformation in prolonged cultures. Clone T2 is one of the spontaneous transformants isolated from R6#13-8 cells (Yam et al., 1999) . The R6#8-2 cell line, a Rat 6 derivative expressing a retroviral backbone vector (Hsiao et al., 1992) , was included in the experiment as a control cell line. Both Rat 6 and R6#8-2 are anchorage independent and negative in nude mice assay (Hsiao et al., 1986; Housey et al., 1988) . All cell lines were grown in Dulbecco's modi®ed Eagle's medium (DMEM) (Gibco) supplemented with 10% calf serum (CS), penicillin and streptomycin at 378C in a humidi®ed incubator with 5% CO 2 in air.
cDNA library screening and DNA sequencing A 351 bp rat cDNA fragment corresponding to nucleotides 7107 ± 7457 of human nmMHC (Phillips et al., 1995) was used as a probe to screen a rat brain cDNA library (Stratagene). 5610 5 plaques were screened. Hybridization was carried out at 428C in 50% deionized formamide, 10% dextran sulfate, 1% SDS and 1 M NaCl. After three rounds of ampli®cation, positive clones were selected and sequenced at both ends using an AutoRead TM sequencing kit (Pharmacia). Complete DNA sequencing was performed on both strands.
Construction of expression vector and stable transfectants of r-nmMHC-B
A cDNA of 6.6 kb containing the entire open reading frame and partial 5' and 3' untranslated sequences of rat nmMHC-B was subcloned into an ecdysone inducible mammalian expression vector, pIND/Hygro (Invitrogen) at NotI and ApaI sites. The resulting expression vector, pIND/nmHMC-B, was co-transfected with the pVgRXR (Invitrogen) carrying bacterial zeocin gene using LipoFectAMINE Plus reagent (BRL). The stable transfectants were selected by cloning rings in a medium containing both hygromycin B (400 mg/ml) and zeocin (300 mg/ml).
Antibodies and Western blot analysis
Con¯uent cultures in 60 mm dishes were washed with cold PBS three times and lysed in 400 ml NET buer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 5 mM EDTA, pH 8.0, 1 mM APMSF, 1 mM E-64, 1 mM pepstatin, 100 mM NaVO 5 , and 10 mg/ml aprotinin) plus 1% NP-40 on ice according to Lu et al. (1992) . For Western blotting analysis, 10 mg of protein extracts were loaded on a 5% SDS ± PAGE. After separation, the proteins were transferred to an Hybond-C nylon membrane (Amersham), reacted to rabbit anti-human nmMHC-A and -B polyclonal antibodies (supplied by Dr RS Adelstein) and visualized by the ECL detection kit (Amersham) according to the instruction manual.
Immunofluorescent staining
Immuno¯uorescent staining was performed according to Martinez et al. (1991) with slight modi®cation. Cells grown on 1% gelatin-coated coverslips were rinsed three times in ice-cold PBS. Cells were ®xed in cold methanol for 5 min. Antibodies speci®c to human nmMHC-A and -B chains (supplied by Dr RS Adelstein) were employed for immunouorescent staining. Specimens were mounted on glass slides with a mounting solution (20% glycerol in PBS).
Growth curves and muristerone A treatment
Cells were seeded at 1.7610 4 cells per 35 mm plate in triplicate and grown in DMEM plus 10% CS medium. The following day, seeded cultures were given dierent concentra-tions of muristerone A. Cell numbers were counted every other day. Mean values and standard deviations of the triplicates were calculated and plotted against time.
Soft agar assay
Tested cells were treated with or without muristerone A for 48 h, then suspended at 1610 4 /60 mm plate with 2 ml of 0.4% Bacto-agar in DMEM containing 20% fetal calf serum (FCS) in the absence or presence of 1 or 5 mM of muristerone A and overlaid above a layer of 5 ml of 1% agar in the same medium in triplicate plates. Cells were refed with a top agar medium biweekly. At day 28, colonies were stained with the vital stain 2-(p-iodopenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium chloride hydrate (INT) for 48 h at 378C in a 5% CO 2 incubator. The number of colonies was scored using the Eagle Eye 1 II System (Stratagene).
Labelling of actin filaments
The cells were grown on coverslips were ®xed with 3.7% formaldehyde in PBS for 10 min at room temperature, then permeablized with 0.2% Triton X-100 in PBS for 1 min at room temperature, washed three times with PBS. The cells were stained with FITC-phalloidin (Sigma) at 5 mg/ml in PBS for 30 min at 378C, then washed with PBS before mounting on microscopic slides with a drop of anti-photobleaching Mowiel 4-88 (Calbiochem, USA) for examination under uorescent microscope.
Nude mice assay
For the in vivo tumorigenicity test, con¯uent cultures of tested cells were either induced or uninduced with 10 mM muristerone A for 48 h. At the end of treatment, cells were harvested and washed with cold PBS once, then resuspended in fresh PBS and counted for cell numbers. Triplicate s.c. inoculations with 3610 6 cells were performed. Experiments were monitored over a two-week duration.
